Paul Budhan

Head of Franchise - GI Oncology & HER2 Tumour Agnostic AstraZeneca

Paul Budhan is the Head of Gastrointestinal Cancers at AstraZeneca UK, where he leads the strategic planning and execution of launches for groundbreaking therapies addressing critical unmet patient needs in Liver, Biliary Tract, and Gastric Cancer. With over 16 years of experience in the pharmaceutical industry, Paul brings a rare combination of expertise in finance and marketing, honed across multiple international markets. Throughout his career, Paul has held pivotal leadership roles, including Chief Financial Officer and senior positions across various oncology therapeutic areas, driving innovation and delivering exceptional results. His track record includes spearheading large-scale organisational efforts to achieve transformative launch success while fostering system-level change that prioritises improved patient outcomes. Renowned for his people-focused leadership style, Paul is deeply committed to cultivating high-performing teams and advancing an outstanding customer experience, setting new benchmarks for excellence in pharmaceutical innovation and patient care.